pharmacoepigenomics

The study sequenced the genomes of 300 deceased patients and found many variants consistent with diseases and adverse drug events the patients encountered during their lives.

NEW YORK (GenomeWeb News) – UCB Canada said today it will support a multi-partner research project funded by Genome Canada and Genome Quebec by helping to study the genomes of epilepsy patients and analyzing genes involved in their responses to medications.

A new partnership between diagnostics manufacturer MDxHealth and Ghent University's laboratory of pharmaceutical biotechnology aims to develop epigenomics-based diagnostics for more personalized treatment of cancers and inflammatory diseases.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.